Founded in 1998 by Charles Corm, CORMCO ® is a private investment company focused on public and private companies in the global tech, biotech, and real estate industries. CORMCO's mission is to deploy patient capital and generate superior long-term returns while embracing stringent risk management methodologies. CORMCO's public equity business includes fundamentally oriented long-focused and crossover strategies, targeting investments in high-quality growth companies. CORMCO's private equity business invests in late stage companies with solid institutional funding, pursuing innovative approaches to new and existing industries, and led by experienced management teams.
CORMCO makes and holds long-term investments in top companies. From 1998 to 2024, CORMCO’s investments generated a 21% annualized return, significantly outperforming the S&P 500 and Nasdaq Composite indexes' annualized returns during the same period (respectively 10% and 14%). CORMCO hedges downside risk to its overall portfolio through a combination of derivatives (futures and options) and decorrelated real estate investments. CORMCO also invests a signicant percentange of its portfolio in precious metals and commodities.
In addition to over $1 billion of its own capital organically generated from past investments, CORMCO has access to over $10 billion through strategic funding partnerships with institutions and UHNWIs, paving the way for stellar global investment opportunities. CORMCO's management team and seasoned advisors make sure it continues to outperform its peers by delivering superior and consistent returns.
© CORMCO, 2025
Neither CORMCO nor any of its personnel offers investment services via the Internet. Any website, service or individual purporting to offer investment services via the Internet is not endorsed by, affiliated with, or otherwise permitted to do so by, CORMCO. This website is not an offer to, or solicitation of, any potential clients or investors for the provision of investment management, advisory or any other related services.